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Objectives
An intervention developed through participatory crowdsourcing methods increased HIV self-testing
among men who have sex with men [MSM; relative risk (RR) = 1.89]. We estimated the long-term
impact of this intervention on HIV transmission among MSM in four cities (Guangzhou, Shenzhen,
Jinan and Qingdao).
Methods
A mathematical model of HIV transmission, testing and treatment among MSM in China was
parameterized using city-level demographic and sexual behaviour data and calibrated to HIV
prevalence, diagnosis and antiretroviral therapy (ART) coverage data. The model was used to
project the HIV infections averted over 20 years (2016–2036) from the intervention to increase
self-testing, compared with current testing rates.
Results
Running the intervention once would avert < 2.2% infections over 20 years. Repeating the
intervention (RR = 1.89) annually would avert 6.4–10.7% of new infections, while further increases
in the self-testing rate (hypothetical RR = 3) would avert 11.7–20.7% of new infections.
Conclusions
Repeated annual interventions would give a three- to seven-fold increase in long-term impact
compared with a one-off intervention. Other interventions will be needed to more effectively
reduce the HIV burden in this population.
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Introduction
Men who have sex with men (MSM) account for over a
quarter of newly diagnosed people living with HIV in
China (25.5% in 2017 [1]) and have high HIV prevalence
(8% in 2015) [2]. Testing rates among MSM living with
HIV in China remain low (54% ever tested; 2017) [3],
reducing the potential impact of HIV treatment as
prevention (TasP) for MSM, due to low awareness of
serostatus and reduced linkage to HIV treatment. HIV
self-testing in China has been shown to reach higher-risk
MSM who do not access facility-based services, but test-
ing rates remain low (29% ever self-testing; 2015) [4].
Recent policy changes in China have resulted in increases
in antiretroviral therapy (ART) coverage among those liv-
ing with HIV (from 67% of HIV-diagnosed individuals on
ART in 2015 to 80% in 2017) [5,6], with similar increases
in MSM [7,8].
One potential way to enhance HIV-testing services uses
crowdsourcing. Crowdsourcing is the process of assigning
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and engaging groups of individuals to solve a problem
together and share the solutions they find with the public
[9]. It can be used within public health settings as a tool
to help develop novel approaches and can increase com-
munity engagement from populations not typically
reached by established intervention strategies [10,11].
There are examples of municipalities and public health
organizations that have made a commitment to repeated
annual HIV crowdsourcing open calls [12], which have
been demonstrated to be sustainable and shown to con-
tribute to community engagement [13]. When compared
with conventional methods for developing public health
messages, several studies have shown that crowdsourcing
approaches save money [14–16].
A large-scale intervention designed to increase HIV test-
ing among MSM was developed using crowdsourcing
methods (national image and local message contests, and
regional strategy designathons) [17]. This resulted in an
intervention which included local testing promotion cam-
paigns and an online HIV self-testing service, tailored for
MSM [18]. This intervention was evaluated using a stepped
wedge, randomized controlled trial conducted in eight
cities in China from August 2016 to August 2017 [18]. In
all, 1381 HIV-status-unknown or HIV-negative MSM who
had not tested for HIV in the past 3 months were recruited
through Blued, a large gay mobile dating application, and
subsequently completed quarterly follow-up surveys to
evaluate their uptake of HIV testing [17]. The trial found an
increase in HIV self-testing among those receiving the
intervention [relative risk (RR)= 1.89, 95% confidence
interval (CI): 1.50–2.38], with no effect on facility-based
HIV testing (RR = 1.00, 95% CI: 0.79–1.26) or condom use
(RR = 1.00, 95% CI: 0.86–1.17) [18]. The intervention was
delivered for a 3-month period in each city, and the
increase in HIV self-testing was found to persist among
MSM during the 12 months of follow-up [18].
Previous studies evaluating the long-term impact of
HIV self-testing are rare [19]. A mathematical model of
community-based HIV self-testing was used in the con-
text of the HIV epidemic in sub-Saharan Africa [20] to
show that targeting specific groups (adult men) achieved
significant impact on new HIV infections (1500 averted
per year) and HIV-related deaths (520 averted per year),
in a population of nine million adults. In a different
mathematical modelling study, home HIV testing/coun-
selling in combination with increasing viral suppression
to 48% in KwaZulu-Natal, South Africa, was shown to
reduce HIV incidence by 40.6% over 10 years [21]. To
our knowledge, there are no mathematical modelling
studies that assess the potential impact of implementing a
self-testing HIV intervention outside of sub-Saharan
Africa, or among MSM.
HIV-testing promotion campaigns often show immedi-
ate but transient effects, with a tapering effectiveness
over longer time periods [22]. Crowdsourced HIV contests
or annual open calls are used to inform HIV programmes,
leading to robust community engagement [12]. This study
aims to quantify the relative effectiveness of a single
one-off HIV-testing intervention and a series of annual
repeated interventions. The trial demonstrated that
crowdsourcing methods are an effective tool for increas-
ing HIV self-testing rates among MSM in China [18].
However, the subsequent impact on HIV transmission was
not measured [17]. This study uses mathematical mod-
elling to estimate the impact on HIV incidence among
MSM of implementing the crowdsourced intervention in
four cities in China. The four cities we study were the lar-
gest cities in the randomized controlled trial – Guangz-
hou, Shenzhen, Jinan and Qingdao – which were also
chosen for their availability of high-quality data and
higher frequency of in-person events during the trial.
Methods
We built a deterministic compartmental model of ordi-
nary differential equations (ODEs) to describe HIV trans-
mission amongst MSM in four cities in China (schematic
in supplement; Fig. S1). The model divides MSM into
uninfected and five HIV-positive infection stages (acute,
CD4 > 500, CD4 351–500, CD4 200–350, CD4 < 200
cells/lL) and five separate states of engagement with HIV
care and treatment (undiagnosed and never tested, undi-
agnosed and ever tested, diagnosed via self-test but not
on ART, diagnosed via facility test but not on ART, on
ART), existing for all CD4 classes. MSM living with HIV
have increased infectiousness in the acute [23] and
CD4 < 200 cells/lL stages [24,25], and reduced infec-
tiousness on ART [5,26].
We further divide MSM into three groups according to
the role taken in anal sex with men: always insertive,
always receptive, and versatile (insertive and receptive).
We also categorize MSM into two risk groups according
to the number of male anal sex partners in the last 3
months (low-risk: two or fewer; high-risk: three or more).
New MSM join the modelled sexually active uninfected
MSM population on sexual debut. HIV transmission
between MSM occurs via anal sex, which is dependent on
role behaviour [27–29], total partners [18] (and their
respective ART status, viral suppression, disease stage and
infectiousness), number of anal sex acts (with efficacy
and use of condom data [30]). See the supplementary
information for further description of the model structure,
model schematic (Fig. S1), HIV transmission, model equa-
tions and sexual mixing (Fig. S2).
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Model calibration
We found estimates of seven metrics to calibrate our
model to: city-level HIV prevalence (up to 12 estimates
per city) [31–34] (CDC), incidence (one estimate) [35,36],
MSM population size (two estimates) [37,38] (CDC), per-
centage of MSM in each risk and role group in 2016 [18],
HIV prevalence by role group (two estimates in Shenzhen,
one in Guangzhou) [34,39,40], national estimates of the
proportion of diagnosed MSM on ART (six data estimates)
[5,41], and provincial estimates (from Shandong only) of
the total percentage of MSM living with HIV who were
diagnosed in 2013 [42]. A summary of these data is
included in Table 1 and in the supplementary information
(model calibration).
We ran the model using one million different parame-
ter combinations in turn. We then selected those runs
which fell within fitting bounds for levels of diagnosis
and MSM population size and calculated log-likelihoods
for each available data point for the other fitting metrics
(HIV prevalence, incidence, percentage in each risk group,
percentage in each role group, HIV prevalence by role).
We summed these log-likelihoods across each data point
and selected the 100 model runs with the largest com-
bined likelihood as our model fits.
Intervention impact
The model fits were used to estimate the impact of each
intervention in comparison to a base case – the ‘standard
of care’ scenario, which assumes that all parameters in
the model remain at their original values in 2016, includ-
ing testing rates and ART initiation. For the intervention
and standard-of-care scenarios, we projected the long-
term epidemic trajectory from 1990 to 2036, with the
interventions starting in 2016.
We simulated the following interventions for each city
(upscaled to all MSM in each city who have not been
tested in the past 3 months):
Interventions
A One-off crowdsourced intervention which increased
self-testing (RR = 1.89) for a period of 1 year, with
self-testing rates subsequently returning to their pre-
intervention values.
B Annual repeated crowdsourced intervention which
increased self-testing (RR = 1.89) for a period of 20
years. This effect over time is hypothetical but is cho-
sen to show the potential impact of sustained annual
repeated crowdsourcing activities (as conducted in
other settings [12,13]).
C Annual repeated crowdsourced intervention with
hypothetical higher impact on self-testing (RR = 3.00)
for a period of 20 years. This hypothetical scenario is
chosen to show the potential impact of a more effec-
tive intervention.
D Annual repeated crowdsourced intervention which
increased self-testing (RR = 1.89) for a period of 20
years, alongside a hypothetical intervention that dou-
bles the rate of ART initiation among diagnosed MSM
from 2016 onwards (resulting in the percentage of
MSM initiating treatment in the last 6 months
increasing from 17–41% to 31–65%). The counterfac-
tual scenario for this intervention was a standard-of-
care scenario with doubled ART initiation rates from
2016 onwards, but no increase in self-testing.
Scenarios A, B and C assume that rates of ART initia-
tion remain constant from 2016 onwards, with 17–41%
of MSM initiating treatment over 6 months.
Measuring impact
We measure the impact of each intervention scenario (A–
D) using the total projected number and percentage of
infections averted among MSM in each city compared
with the current standard of care.
Results
Model fits
For the selected 100 model fits for each city, the model
outputs agreed well with the data on HIV prevalence, per-
centage diagnosed, percentage on ART, population size,
percentage in each risk and role group, and HIV preva-
lence by role, but underestimated the HIV incidence rate
(Fig. 1 and Fig. S8). The discrepancy between the HIV
incidence estimates and the model may be due to the
incidence estimates coming from different cohorts of
MSM. The best fits underestimated ART coverage early
on (2005–2006) but captured more recent levels (Fig. 1).
The full prior and posterior parameter ranges can be
found in Table S1 and Figs S9–S12.
Standard of care (no intervention)
Figure 1 shows the expected prevalence trends under the
standard-of-care (no intervention) scenario. The model
projects that HIV prevalence among MSM peaked around
2015, before declining due to earlier increases in testing,
ART eligibility and viral suppression (or remaining con-
stant in Qingdao – due to lower condom use, self-testing
© 2021 The Authors.
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Table 1 Key parameters (a) and fitting metrics (b) used in the model (summary of 95% confidence interval uncertainty ranges) for Guangz-
hou, Shenzhen, Jinan and Qingdao cities
Parameters Guangzhou Shenzhen Jinan Qingdao Source
(a) Sexual behaviour parameters
Average number of partners per year
Low risk, always insertive 1.6–2.6 1.6–2.6 1.3–2.2 1.6–2.7 Baseline trial data [13]
Low risk, versatile 1.4–2.1 1.6–2.3 1.4–2.2 1.5–2.2 Baseline trial data [13]
Low risk, always receptive 1.2–2.2 1.2–2.3 1.4–2.5 1.7–2.8 Baseline trial data [13]
High risk, always insertive 11.8–18.9 14.6–22.4 3.6–22.4 12.3–24.0 Baseline trial data [13]
High risk, versatile 12.4–19.9 12.5–20.8 9.3–19.5 12.6–22.9 Baseline trial data [13]
High risk, always receptive 11.2–19.9 10.0–27.2 7.6–20.7 10.7–23.9 Baseline trial data [13]
Anal sex acts per MSM partnership per year (assumed same for all cities)
Low risk 17–22 Baseline trial data [13]
High risk 11–16 Baseline trial data [13]
Percentage of sex acts in which a condom is used
Low risk 64–81 68–83 64–80 67–82 Baseline trial data [13]
High risk 73–92 67–89 61–88 60–87 Baseline trial data [13]
(b) Intervention parameters
Initial rate of facility-based testing
per year
0.1–0.2 (2005) 0.4–0.6 (2006) 0.3–0.4 (mid 2005) 0.3–0.4 (2006) City-level estimates
[24–28]
Annual testing rates
First self-test, low risk 0.14–0.30 0.07–0.15 0.19–0.23 0.10–0.30 Baseline trial data [13]
First facility test, low risk 0.10–0.20 Baseline trial data [13]
Self-test if not tested last
3 months
0.1–0.2 0.1–0.2 0.1–0.3 0.2–0.4 Baseline trial data [13]
Self-test, if tested in last 3 months 0.7–1.4 0.7–1.2 0.7–1.4 0.6–0.9 Baseline trial data [13]
Overall facility testing 0.5–0.6 Baseline trial data [13]
Relative risk ratio for testing among high-risk MSM vs. low-risk MSM
Self-testing 1.1–1.5 Baseline trial data [13]
Facility testing 1.2–1.5 Baseline trial data [13]
Rate of dropout from ART per year 0.02–0.04 National and
Guangdong [23,32]
(c) Fitting metrics






9687–19 373 (2009) 29 300–46 200 (2016) [42,43], Shenzhen
CDC 2016 [48],




12 676–18 830 (2017) 28 000–51 000 (2018)
HIV prevalence (%, 95% CI)
2005 ND 0.0–3.3 ND ND SZ CDC
2006 0.4–2.9 1.0–3.8 ND ND GZ, SZ CDC, [36]
2007 ND 2.9–5.9 ND ND SZ CDC
2008 2.3–7.2 5.2–8.5 ND ND GZ, SZ CDC [37]
2009 2.0–5.8 7.2–10.9 ND ND GZ, SZ CDC [37]
2010 5.0–10.2 6.1–9.0 1.2–2.9 0.0–1.2 GZ, SZ, SD CDC [37]
2011 6.4–12.1 5.3–8.9 3.9–6.2 0.0–1.2 GZ, SZ, SD CDC [37,39]
2012 7.0–12.9 7.2–12.4 5.9–7.8 0.0–1.6 GZ, SZ, SD CDC [37,39]
2013 8.9–13.8 7.6–12.1 9.5–12.1 2.3–6.5 GZ, SZ, SD CDC [37,39]
2014 9.7–14.9 10.9–16.4 10.9–13.5 3.3–5.6 GZ, SZ, SD CDC [38,39]
2015 8.5–13.5 6.5–11.6 7.1–9.5 2.2–3.8 GZ, SZ, SD CDC [38,39]
2016 ND 9.1–16.0 ND ND SZ CDC, [39]
HIV incidence rate (per 100 person-
years)
2.9–8.7 (2009.5) 4.6–11.9 (2010) ND ND [40,41]




Percentage of diagnosed MSM on ART
2005 18.9–40.8 National estimate [5]
2007 20.5–37.1 National estimate [5]
2009 26.7–40.0 National estimate [5]
2011 38.0–49.6 National estimate [5]
2013 50.7–60.4 National estimate [5]
2015 62.9–70.6 National estimate [5]
GZ, Guangzhou; SZ, Shenzhen; JN, Jinan; QD, Qingdao; SD, Shandong; CDC, Center for Disease Control; ND, no data; MSM, men who have sex with
men; ART, antiretroviral therapy.
More detailed information can be found in Table S1.
*Indicates  20% on lower and upper bounds.
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and higher partner numbers) and by 2036 would reach
11.4% in Guangzhou, 12.2% in Shenzhen, 10.2% in Jinan
and 5.0% in Qingdao, while the model suggests that HIV
incidence peaked in each city around 2013 (due to
increases in ART coverage). We project that the total
percentage of MSM diagnosed would reach 92–93% in all
cities by 2036, the percentage of diagnosed MSM on ART
would be 86–88%, the percentage of all infected MSM on
ART would be 79–82% (Fig. 2) and viral suppression rates
would be 78–81% (ranges are median values for each city).
Fig. 1 Comparison of the model projections for each city against data on HIV prevalence, incidence per 100 person-years (py), percentage on
antiretroviral therapy (ART) if diagnosed and percentage diagnosed. Projections are shown for Guangzhou (a–d), Shenzhen (e–h), Jinan (i–l)
and Qingdao (m–p), with median (black line) and 95% credible interval (blue shaded area) being displayed for 100 model fits for each city.
Empty red squares indicate HIV diagnosis data that were fitted to (accepted if confidence interval) and red circles indicate those data that are
included in the likelihood estimation to determine the best-fitting model runs. The blue dot represents validation data from 2018 [86.5% of
diagnosed men who have sex with men (MSM) on ART in a recently published UNAIDS report [8]]. Other metrics used in model fitting can be
seen in Fig. S8. [Colour figure can be viewed at wileyonlinelibrary.com]
© 2021 The Authors.
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Intervention A: One-off crowdsourced intervention
Over twenty years (2016–2036), a one-off crowdsourced
intervention in 2016 (given to those MSM who have not
tested in the past 3 months) increasing self-testing for
1 year (intervention A) was projected to avert 0.9–2.2%
of new HIV infections among MSM compared with the
standard of care (Table 2). The total infections averted by
the one-off intervention would be 215 in Guangzhou,
266 in Shenzhen, 59 in Jinan and 85 in Qingdao, with
Fig. 2 The effect of each of the four interventions introduced in 2016 on diagnosis levels and percentage of men who have sex with men
(MSM) living with HIV on antiretroviral therapy (ART) in Guangzhou (a, b), Shenzhen (c, d), Jinan (e, f) and Qingdao (g, h) for the 1-year HIV
self-testing intervention A (red dashed), the 20-year intervention B (green dashed), the higher-impact 20-year intervention C (blue dashed),
intervention D (orange) and the standard of care (black). [Colour figure can be viewed at wileyonlinelibrary.com]
© 2021 The Authors.
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more infections averted in the cities with higher MSM
population sizes (Fig. S8). The model projected that there
would be very little change after 20 years in relative
diagnosis levels, or ART coverage (< 0.1%) under inter-
vention A in all cities as compared with the base case
(Fig. 2).
Intervention B: Annual repeated crowdsourced
intervention
Repeating the crowdsourced intervention each year for 20
years (increasing self-testing over the 20 years) averted a
total of 7.3% HIV infections in Guangzhou, 6.4% in
Shenzhen, 8.7% in Jinan and 10.7% in Qingdao over that
period (Table 2). Across the cities, intervention B averted
three- to seven-fold more infections than the 1-year
intervention A (with similar increases in total infections
averted: four- to seven-fold). While Qingdao had the
highest percentage of infections averted (10.7%), this
only equated to 411 infections, while Shenzhen had the
lowest percentage of infections averted (6.4%) but the
highest total infections averted (1798), due to higher pop-
ulation size. The model also projected that intervention B
would lead to small increases in relative diagnosis levels
(1.6–2.2%; Fig. 2) and ART coverage (1.5–2.2% among
all infected MSM) in all four cities by 2036. The city with
the greatest increase in ART coverage, Qingdao (2.2%),
also had the highest percentage of infections averted
(10.7%).
Intervention C: Hypothetical annual repeated
crowdsourced intervention with higher impact on
self-testing
If we assume that the repeated annual crowdsourced
intervention has a higher impact (RR = 3.00) on self-test-
ing (i.e. a hypothetically more effective future
intervention) then we achieve a further increase in the
percentage of infections averted to 11.7–20.7% across the
different cities over 20 years, showing a 1.6- to 1.9-fold
increase in both percentage of infections averted and
total infections averted when compared with intervention
B. Again, Shenzhen had the highest total of infections
averted (3341) and the lowest percentage of infections
averted (11.7%) among the four cities. Intervention C also
increased diagnosis levels in 2036 by 2.6–4.2% and
increased the proportion of all infected MSM on ART by
2.4–4.4% (relative increase) in all cities as compared with
the standard of care (Fig. 2).
Intervention D: Annual repeated crowdsourced
intervention in the context of expanded ART
initiation
The incremental impact of the repeated annual crowd-
sourced intervention in the context of expanded ART
coverage averted 8.2–12.3% of infections across the four
modelled cities. The incremental impact on percentage of
infections averted was 1.1–1.3 times greater than that of
intervention B (the same repeated annual crowdsourced
intervention but with stable ART initiation rates) but was
equal or 1.3 times smaller for total infections averted (as
fewer infections occurred in the standard-of-care arm
with expanded ART initiation). After 20 years, when
compared with the counterfactual of doubling ART initia-
tion alone, diagnosis levels were increased by 1.4–1.9%,
and ART coverage among all infected MSM by 1.4–2.0%.
Discussion
This mathematical modelling study estimated that a one-
off crowdsourced testing intervention [18] would margin-
ally reduce cumulative HIV incidence, preventing a total
of 0.9–2.2% new infections over a 20-year period (2016 –
Table 2 Intervention impact compared with existing standard of care over 20 years (2016–2036) in four cities in China. Data are medians
(95% credible interval)
Intervention Guangzhou Shenzhen Jinan Qingdao
Intervention A: One-off intervention (RR = 1.89)
% of infections averted 2.1 (0.8–5.4) 0.9 (0.3–3.2) 2.1 (0.7–4.5) 2.2 (0.6–5.6)
Total infections averted 215 (70–442) 266 (88–703) 59 (19–154) 85 (23–226)
Intervention B: Annual repeated intervention (RR = 1.89)
% of infections averted 7.3 (3.5–17.5) 6.4 (2.8–15.7) 8.7 (4.1–15.0) 10.7 (3.4–18.3)
Total infections averted 776 (300–1601) 1798 (753–3571) 256 (110–529) 411 (119–1000)
Intervention C: Repeated annual intervention with higher impact (RR = 3.00)
% of infections averted 12.0 (6.8–26.5) 11.7 (5.4–23.2) 14.9 (9.2–25.6) 20.7 (10.9–34.6)
Total infections averted 1213 (605–2325) 3341 (1618–5848) 438 (241–826) 724 (310–1651)
Intervention D: Repeated annual intervention (RR = 1.89) in the context of doubled ART initiation rates (31–65% initiating within 6 months compared with
17–41%)
% of infections averted 9.2 (4.1–22.2) 8.2 (3.7–20.0) 10.8 (5.2–19.0) 12.3 (4.4–22.1)
Total infections averted 712 (290–1492) 1797 (838–3472) 228 (103–470) 310 (93–848)
© 2021 The Authors.
HIV Medicine published by John Wiley & Sons Ltd on behalf of British HIV Association
HIV Medicine (2021), 22, 467--477
Modelling HIV testing among MSM in China 473
2036) across all four cities in the study (Guangzhou,
Shenzhen, Jinan and Qingdao). These impact projections
substantially increased (three- to seven-fold) if the inter-
vention was repeated each year over a 20-year period (in-
tervention B), or if the intervention increased the
likelihood of self-testing three-fold rather than 1.89-fold
(up to 1.6–1.9 times more effective than intervention B).
The incremental impact of the long-duration intervention
on new infections would be maintained if ART initiation
rates were increased as might be expected in future years
(1.1- to 1.3-fold on infections averted).
Between cities, there was variability in our predicted
levels of impact despite implementing the same interven-
tion in each city, due to different initial conditions, data
and parameters within each city (each representing differ-
ent baseline levels of testing, sexual behaviour, HIV
prevalence, diagnosis and ART coverage data). The total
percentage of infections averted varied up to 2.5-fold
between cities, with higher impact achieved in Qingdao,
which had lower baseline condom use and self-testing
rates, as well as higher partner numbers. Likewise, the
total infections averted varied up to eight-fold between
cities, with higher impact achieved in cities with larger
population size (Shenzhen). For example, Guangzhou and
Shenzhen have similar absolute impact (215 and 266
infections averted in intervention A), even though
Guangzhou has a larger relative impact (2.1% and 0.9%
of infections averted) due to Shenzhen having a larger
MSM population size.
Our model predicts that HIV prevalence among MSM
in 2036 under the current standard of care would be
11.4% in Guangzhou, 12.2% in Shenzhen, 10.2% in Jinan
and 5.0% in Qingdao. These estimates are in line with
projections from other recent China-specific MSM HIV
modelling studies focusing on the national level (11%
[43] to 22% [44] in 2037), suggesting that the HIV preva-
lence among MSM living in China will gradually decrease
from current levels, although slowly and with some
uncertainty. Our model predictions account for recent
policy changes since 2016, making ART available to
everyone and increasing testing rates (e.g. introduction of
self-testing in 2013 [45]). This standard-of-care result
highlights the need to prioritize interventions that con-
tinue to focus on reducing the HIV disease burden among
MSM in China. Another modelling study focusing on
MSM living in Beijing [46] predicted that if 70% of MSM
were tested in a year, and if, of those tested, 70% were
treated, then new HIV infections would decline by 50–
70%, a greater impact than any of the scenarios we
model in this study. However, their model did not take
into account historical changes in HIV-testing and ART
coverage, which can greatly affect HIV incidence trends,
and looked at a ‘test and treat’ intervention rather than
increasing testing alone. Another study in sub-Saharan
Africa showed that targeting adult men with community-
based HIV self-testing could avert 1500 HIV infections
per year in the context of a country of nine million
adults [20], which equates to an 8.5% reduction, similar
to the impact predicted in our study with a repeated
annual intervention. The sub-Saharan African study
assumed that 30% of HIV-testing services for men were
replaced with community-based self-testing.
This study is a rare example [19,47] of a model esti-
mating how increasing HIV self-testing impacts HIV
transmission and is the first model to assess the potential
impact of implementing a crowdsourced HIV-testing
intervention over a long time period. Our mathematical
model made use of a wide variety of data sources, speci-
fic to MSM in China and specific to the individual cities
we studied. In combination with the crowdsourced trial
data at baseline [18] and Shandong and Guangdong CDC
data, this ensured that our model results were feasible
and realistic.
However, in some cases, we were unable to use local
estimates, and instead used parameters from similar
studies wherever possible. ART dropout rates were not
available for all cities and were taken from national or
regional estimates [48,49], and in the absence of local
data, diagnosis and ART coverage levels were fitted to
Shandong [42] and national estimates [5], respectively,
meaning that we may not have fully captured the care
cascade in each city. This means that if we have overes-
timated levels of diagnosis or ART coverage, we will
have underestimated the potential intervention impact. If
these fitted estimates were to change dramatically then
this would have consequences for our impact measures
and, ideally, we would have city-specific parameters for
all cities. Most of the sexual behavioural data used to
inform the model parameters came from trial partici-
pants, who may not be representative of the wider MSM
population in these cities. National estimates for partner
numbers [50,51] and condom use [51] among MSM fall
within the overall ranges used in our model, although
our city-specific estimates suggest slightly higher partner
numbers and lower condom use than these national esti-
mates.
We also had no data on the initial size of the MSM
population in 1990, the rate at which new MSM joined
the sexually active population, and the ART initiation
rate from both self-testers and facility testers. However,
we ensured that we captured the underlying parameter
value by allowing the maximum range of variation in
our sampling method. For the ART initiation rate, we also
assumed identical behaviour for those diagnosed via
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facility and self-testing in the absence of data on the dif-
ferences between linkage following facility/self-testing in
China. If slower ART initiation follows from being diag-
nosed via self-testing, then our model would have over-
estimated the impact of the crowdsourced testing
intervention. Although crowdsourcing involves local
community engagement, we had no pre-specified metrics
to measure the extent of community engagement. We
also did not include changes in behaviour following HIV
diagnosis because this was not the focus of the trial or
this analysis, which means our findings could underesti-
mate the potential impact of a self-testing intervention if
substantial reductions in risk behaviour did occur after a
man is diagnosed with HIV. Pre-exposure prophylaxis
(PrEP) use was also not considered, as PrEP has only
recently been licensed for HIV prevention in China [52].
It will be important for future modelling studies to assess
the impact of PrEP for MSM on the HIV epidemic in
China.
Conclusions
Our modelling study suggests that the crowdsourced self-
testing intervention with impacts lasting for a 1-year per-
iod would only have a small long-term impact on HIV
transmission among MSM in China. Repeating the inter-
vention annually would have a greater impact (three- to
seven-fold). These results, in parallel with our projections
of the HIV prevalence (gradually decreasing from current
levels, although slowly) among MSM in each of the four
cities (5–12% in 2036 without further intervention), indi-
cate the need to prioritize increasing the proportion of
diagnosed MSM on ART and increasing viral suppression
on ART, in order to reduce the HIV burden in the MSM
population in China.
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